In colorectal cancer, RPF2 is significantly overexpressed, promoting epithelial-mesenchymal transition (EMT) via the AKT/GSK-3β signaling pathway, thereby enhancing migration and invasion of colorectal cancer cells in vitro and vivo [46]. The gene discussed is GSK3B; the disease is colorectal cancer.